Evogene LtdEVGN
Price$0.44

Valuation

How Intrinsic Value compares with model outputs

Intrinsic Value not published yet, our data-reliability standards weren't met; method estimates belowbased on filings through 31 Dec 2025
Market Price $0.44Price as of 1 Oct 2026

Valuation methods vs. Market Price

Company vs. peer median Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Assumptions

ParameterValue
Years 1–5: analyst growth pathFive-year total matches analyst consensus exactly. Year 1: 5.0% (near-term consensus, capped) · years 2–5: 24.2%/yr (balance of the path).20.1% per year
Years 6–10: glide to demonstrated growth
Per-year rates
Yr 623.3%Yr 722.5%Yr 821.7%Yr 920.8%Yr 1020.0%
24.2% → 20.0%
Years 11–20: glide to long-run rate
Per-year rates
Yr 1118.3%Yr 1216.6%Yr 1314.9%Yr 1413.2%Yr 1511.5%Yr 169.8%Yr 178.1%Yr 186.4%Yr 194.7%Yr 203.0%
20.0% → 3.0%
Beyond year 20: terminal growthPerpetual long-run rate3.0%
Discount rate (cost of equity) 8.5%
Volatility vs market (adjusted beta)0.80

Valuation Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Assumptions Sandbox Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Compare with peers

Search any company to compare valuation, profitability, returns, growth, and financial strength side by side.

Compare the target company plus 1 peer. Sign in / Sign up to compare a maximum of 3 peers.

Best in rowHigher is betterLower is better—Data not available
TargetEvogene LtdEVGNHealth Care
Valuation
P/E—
P/S2.1×
P/B0.3×
EV / Revenue2.3×
EV / EBITDA—
Profitability
Gross margin61.1%
Operating margin-943.1%
Net margin-203.1%
FCF margin-353.9%
Returns
ROE-65.4%
ROA-39.0%
ROIC—
Growth
Revenue growth (YoY)-30.9%
5-yr fwd EPS growth20.1%
Financial strength
Debt / Equity0.00×
Current ratio4.54×
Altman Z-Score—
Interest coverage—
Dividend yield—

Best value in each row is highlighted. Figures are periodic snapshots from the same filings used across each dossier; a dash means the figure is not available.

AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.